The retail outlets include mass merchandisers such as Wal-Mart and Target, food store chains such as SuperValu, Kroger and Safeway, and regional drugstores.
These retailers were selected according to various material criteria such as cost of entry, geography, demographics and consumer preference.
The company plans on embarking on a national marketing campaign to promote, increase distribution for LipiGesic M to support its retail expansion effort.
Recently, LipiGesic M has been confirmed as an over-the-counter medication for the treatment of acute migraine pain.
LipiGesic M is stocked in 15,000 stores including in some of the largest drug store chains in the US, such as Walgreen’s and CVS Pharmacy.